Development and clinical validation of a novel six-gene signature for accurately predicting the recurrence risk of patients with stage II/III colorectal cancer

BACKGROUND: A large number of patients with stage II/III colorectal cancer (CRC) have a high recurrence rate after radical resection. We aimed to develop a novel tool to stratify patients with different recurrence-risk for optimizing decision-making in post-operative surveillance and therapeutic reg...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Zaoqu, Lu, Taoyuan, Li, Jing, Wang, Libo, Xu, Kaihao, Dang, Qin, Guo, Chunguang, Liu, Long, Jiao, Dechao, Sun, Zhenqiang, Han, Xinwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265123/
https://www.ncbi.nlm.nih.gov/pubmed/34233675
http://dx.doi.org/10.1186/s12935-021-02070-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265123/
https://www.ncbi.nlm.nih.gov/pubmed/34233675
http://dx.doi.org/10.1186/s12935-021-02070-z

Ejemplares similares